Tsumura & Co.
Tsumura & Co. (TSMRF) Stock Competitors & Peer Comparison
See (TSMRF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TSMRF | $23.20 | +0.00% | 1.7B | 10.04 | $2.31 | +4.12% |
| MKGAF | $153.71 | +1.05% | 67.7B | 22.97 | $6.78 | +1.65% |
| MKKGY | $30.38 | +1.03% | 65.9B | 22.13 | $1.37 | +1.70% |
| IPSEY | $46.60 | -0.72% | 61.6B | 30.26 | $1.54 | +0.86% |
| TKPHF | $32.10 | -1.53% | 50.7B | 42.80 | $0.75 | +4.06% |
| HLNCF | $4.80 | +3.90% | 42.5B | 19.20 | $0.25 | +1.99% |
| SDZNY | $83.38 | +1.70% | 36B | 39.80 | $2.09 | +1.23% |
| TEVJF | $30.19 | +0.00% | 35.2B | 24.95 | $1.21 | N/A |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
Stock Comparison
TSMRF vs MKGAF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, MKGAF has a market cap of 67.7B. Regarding current trading prices, TSMRF is priced at $23.20, while MKGAF trades at $153.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas MKGAF's P/E ratio is 22.97. In terms of profitability, TSMRF's ROE is +0.09%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, TSMRF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check MKGAF's competition here
TSMRF vs MKKGY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, MKKGY has a market cap of 65.9B. Regarding current trading prices, TSMRF is priced at $23.20, while MKKGY trades at $30.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas MKKGY's P/E ratio is 22.13. In terms of profitability, TSMRF's ROE is +0.09%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, TSMRF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check MKKGY's competition here
TSMRF vs IPSEY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, IPSEY has a market cap of 61.6B. Regarding current trading prices, TSMRF is priced at $23.20, while IPSEY trades at $46.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas IPSEY's P/E ratio is 30.26. In terms of profitability, TSMRF's ROE is +0.09%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, TSMRF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check IPSEY's competition here
TSMRF vs TKPHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, TKPHF has a market cap of 50.7B. Regarding current trading prices, TSMRF is priced at $23.20, while TKPHF trades at $32.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas TKPHF's P/E ratio is 42.80. In terms of profitability, TSMRF's ROE is +0.09%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, TSMRF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check TKPHF's competition here
TSMRF vs HLNCF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HLNCF has a market cap of 42.5B. Regarding current trading prices, TSMRF is priced at $23.20, while HLNCF trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HLNCF's P/E ratio is 19.20. In terms of profitability, TSMRF's ROE is +0.09%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, TSMRF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check HLNCF's competition here
TSMRF vs SDZNY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SDZNY has a market cap of 36B. Regarding current trading prices, TSMRF is priced at $23.20, while SDZNY trades at $83.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SDZNY's P/E ratio is 39.80. In terms of profitability, TSMRF's ROE is +0.09%, compared to SDZNY's ROE of +0.09%. Regarding short-term risk, TSMRF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check SDZNY's competition here
TSMRF vs TEVJF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, TEVJF has a market cap of 35.2B. Regarding current trading prices, TSMRF is priced at $23.20, while TEVJF trades at $30.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas TEVJF's P/E ratio is 24.95. In terms of profitability, TSMRF's ROE is +0.09%, compared to TEVJF's ROE of +0.21%. Regarding short-term risk, TSMRF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check TEVJF's competition here
TSMRF vs TAIPY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, TSMRF is priced at $23.20, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, TSMRF's ROE is +0.09%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, TSMRF is more volatile compared to TAIPY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check TAIPY's competition here
TSMRF vs ESALY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, TSMRF is priced at $23.20, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas ESALY's P/E ratio is 20.54. In terms of profitability, TSMRF's ROE is +0.09%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, TSMRF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check ESALY's competition here
TSMRF vs BIOVF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, BIOVF has a market cap of 16.4B. Regarding current trading prices, TSMRF is priced at $23.20, while BIOVF trades at $47.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas BIOVF's P/E ratio is 169.55. In terms of profitability, TSMRF's ROE is +0.09%, compared to BIOVF's ROE of +0.02%. Regarding short-term risk, TSMRF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check BIOVF's competition here
TSMRF vs SGIOF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SGIOF has a market cap of 16.1B. Regarding current trading prices, TSMRF is priced at $23.20, while SGIOF trades at $18.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SGIOF's P/E ratio is 14.99. In terms of profitability, TSMRF's ROE is +0.09%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, TSMRF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check SGIOF's competition here
TSMRF vs SGIOY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SGIOY has a market cap of 16B. Regarding current trading prices, TSMRF is priced at $23.20, while SGIOY trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SGIOY's P/E ratio is 14.92. In terms of profitability, TSMRF's ROE is +0.09%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, TSMRF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check SGIOY's competition here
TSMRF vs IPSEF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, TSMRF is priced at $23.20, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, TSMRF's ROE is +0.09%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, TSMRF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check IPSEF's competition here
TSMRF vs ESALF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, ESALF has a market cap of 7.9B. Regarding current trading prices, TSMRF is priced at $23.20, while ESALF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas ESALF's P/E ratio is 32.56. In terms of profitability, TSMRF's ROE is +0.09%, compared to ESALF's ROE of +0.04%. Regarding short-term risk, TSMRF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check ESALF's competition here
TSMRF vs ESAIY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, ESAIY has a market cap of 6.9B. Regarding current trading prices, TSMRF is priced at $23.20, while ESAIY trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas ESAIY's P/E ratio is 27.76. In terms of profitability, TSMRF's ROE is +0.09%, compared to ESAIY's ROE of +0.04%. Regarding short-term risk, TSMRF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check ESAIY's competition here
TSMRF vs BCHMF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, BCHMF has a market cap of 6.8B. Regarding current trading prices, TSMRF is priced at $23.20, while BCHMF trades at $91.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas BCHMF's P/E ratio is 36.06. In terms of profitability, TSMRF's ROE is +0.09%, compared to BCHMF's ROE of +0.11%. Regarding short-term risk, TSMRF is more volatile compared to BCHMF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check BCHMF's competition here
TSMRF vs GZPHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, TSMRF is priced at $23.20, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, TSMRF's ROE is +0.09%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, TSMRF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check GZPHF's competition here
TSMRF vs LVZPF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, TSMRF is priced at $23.20, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, TSMRF's ROE is +0.09%, compared to LVZPF's ROE of +0.14%. Regarding short-term risk, TSMRF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check LVZPF's competition here
TSMRF vs HLUBF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, TSMRF is priced at $23.20, while HLUBF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HLUBF's P/E ratio is 9.32. In terms of profitability, TSMRF's ROE is +0.09%, compared to HLUBF's ROE of +0.15%. Regarding short-term risk, TSMRF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check HLUBF's competition here
TSMRF vs HLBBF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HLBBF has a market cap of 5.8B. Regarding current trading prices, TSMRF is priced at $23.20, while HLBBF trades at $7.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HLBBF's P/E ratio is 14.29. In terms of profitability, TSMRF's ROE is +0.09%, compared to HLBBF's ROE of +0.15%. Regarding short-term risk, TSMRF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check HLBBF's competition here
TSMRF vs SFOSF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SFOSF has a market cap of 5.8B. Regarding current trading prices, TSMRF is priced at $23.20, while SFOSF trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SFOSF's P/E ratio is 11.45. In terms of profitability, TSMRF's ROE is +0.09%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, TSMRF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check SFOSF's competition here
TSMRF vs SMDPY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SMDPY has a market cap of 4.9B. Regarding current trading prices, TSMRF is priced at $23.20, while SMDPY trades at $10.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SMDPY's P/E ratio is 6.47. In terms of profitability, TSMRF's ROE is +0.09%, compared to SMDPY's ROE of +0.42%. Regarding short-term risk, TSMRF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check SMDPY's competition here
TSMRF vs LABFF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, TSMRF is priced at $23.20, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas LABFF's P/E ratio is 28.95. In terms of profitability, TSMRF's ROE is +0.09%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, TSMRF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check LABFF's competition here
TSMRF vs DNPUF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, DNPUF has a market cap of 4.6B. Regarding current trading prices, TSMRF is priced at $23.20, while DNPUF trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas DNPUF's P/E ratio is 6.01. In terms of profitability, TSMRF's ROE is +0.09%, compared to DNPUF's ROE of +0.42%. Regarding short-term risk, TSMRF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check DNPUF's competition here
TSMRF vs SGFEF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, TSMRF is priced at $23.20, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SGFEF's P/E ratio is 20.41. In terms of profitability, TSMRF's ROE is +0.09%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, TSMRF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check SGFEF's competition here
TSMRF vs HKMPY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HKMPY has a market cap of 4.3B. Regarding current trading prices, TSMRF is priced at $23.20, while HKMPY trades at $39.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HKMPY's P/E ratio is 10.84. In terms of profitability, TSMRF's ROE is +0.09%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, TSMRF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check HKMPY's competition here
TSMRF vs HKMPF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HKMPF has a market cap of 4.3B. Regarding current trading prices, TSMRF is priced at $23.20, while HKMPF trades at $19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HKMPF's P/E ratio is 11.02. In terms of profitability, TSMRF's ROE is +0.09%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, TSMRF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check HKMPF's competition here
TSMRF vs APNHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, APNHF has a market cap of 3.9B. Regarding current trading prices, TSMRF is priced at $23.20, while APNHF trades at $8.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas APNHF's P/E ratio is -34.80. In terms of profitability, TSMRF's ROE is +0.09%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, TSMRF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check APNHF's competition here
TSMRF vs CAMRF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CAMRF has a market cap of 3.8B. Regarding current trading prices, TSMRF is priced at $23.20, while CAMRF trades at $63.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CAMRF's P/E ratio is 51.89. In terms of profitability, TSMRF's ROE is +0.09%, compared to CAMRF's ROE of +0.16%. Regarding short-term risk, TSMRF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check CAMRF's competition here
TSMRF vs APNHY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, APNHY has a market cap of 3.6B. Regarding current trading prices, TSMRF is priced at $23.20, while APNHY trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas APNHY's P/E ratio is -32.60. In terms of profitability, TSMRF's ROE is +0.09%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, TSMRF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check APNHY's competition here
TSMRF vs LBTSF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, TSMRF is priced at $23.20, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, TSMRF's ROE is +0.09%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, TSMRF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check LBTSF's competition here
TSMRF vs CHSYF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, TSMRF is priced at $23.20, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, TSMRF's ROE is +0.09%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, TSMRF is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CHSYF's competition here
TSMRF vs HYPMY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HYPMY has a market cap of 3.1B. Regarding current trading prices, TSMRF is priced at $23.20, while HYPMY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HYPMY's P/E ratio is 8.50. In terms of profitability, TSMRF's ROE is +0.09%, compared to HYPMY's ROE of +0.13%. Regarding short-term risk, TSMRF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check HYPMY's competition here
TSMRF vs INVVY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, TSMRF is priced at $23.20, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas INVVY's P/E ratio is -62.42. In terms of profitability, TSMRF's ROE is +0.09%, compared to INVVY's ROE of -0.42%. Regarding short-term risk, TSMRF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check INVVY's competition here
TSMRF vs IZQVF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, TSMRF is priced at $23.20, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, TSMRF's ROE is +0.09%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, TSMRF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check IZQVF's competition here
TSMRF vs CURLF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CURLF has a market cap of 2.8B. Regarding current trading prices, TSMRF is priced at $23.20, while CURLF trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CURLF's P/E ratio is -26.92. In terms of profitability, TSMRF's ROE is +0.09%, compared to CURLF's ROE of -0.13%. Regarding short-term risk, TSMRF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check CURLF's competition here
TSMRF vs ULIHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, ULIHF has a market cap of 2.4B. Regarding current trading prices, TSMRF is priced at $23.20, while ULIHF trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas ULIHF's P/E ratio is 7.75. In terms of profitability, TSMRF's ROE is +0.09%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, TSMRF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check ULIHF's competition here
TSMRF vs NPNKF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, TSMRF is priced at $23.20, while NPNKF trades at $31.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas NPNKF's P/E ratio is 11.29. In terms of profitability, TSMRF's ROE is +0.09%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, TSMRF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check NPNKF's competition here
TSMRF vs HTSUF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, TSMRF is priced at $23.20, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, TSMRF's ROE is +0.09%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, TSMRF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check HTSUF's competition here
TSMRF vs DMPHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, DMPHF has a market cap of 2B. Regarding current trading prices, TSMRF is priced at $23.20, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, TSMRF's ROE is +0.09%, compared to DMPHF's ROE of +0.21%. Regarding short-term risk, TSMRF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check DMPHF's competition here
TSMRF vs ARSUF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, ARSUF has a market cap of 1.9B. Regarding current trading prices, TSMRF is priced at $23.20, while ARSUF trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas ARSUF's P/E ratio is 18.42. In terms of profitability, TSMRF's ROE is +0.09%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, TSMRF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check ARSUF's competition here
TSMRF vs DUTV Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, TSMRF is priced at $23.20, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas DUTV's P/E ratio is N/A. In terms of profitability, TSMRF's ROE is +0.09%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, TSMRF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check DUTV's competition here
TSMRF vs GTBIF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, GTBIF has a market cap of 1.9B. Regarding current trading prices, TSMRF is priced at $23.20, while GTBIF trades at $8.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas GTBIF's P/E ratio is 15.76. In terms of profitability, TSMRF's ROE is +0.09%, compared to GTBIF's ROE of +0.07%. Regarding short-term risk, TSMRF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check GTBIF's competition here
TSMRF vs HMDCF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HMDCF has a market cap of 1.9B. Regarding current trading prices, TSMRF is priced at $23.20, while HMDCF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HMDCF's P/E ratio is 4.08. In terms of profitability, TSMRF's ROE is +0.09%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, TSMRF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check HMDCF's competition here
TSMRF vs TCNNF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, TCNNF has a market cap of 1.8B. Regarding current trading prices, TSMRF is priced at $23.20, while TCNNF trades at $9.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas TCNNF's P/E ratio is -23.62. In terms of profitability, TSMRF's ROE is +0.09%, compared to TCNNF's ROE of -0.07%. Regarding short-term risk, TSMRF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check TCNNF's competition here
TSMRF vs NPPNY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, NPPNY has a market cap of 1.8B. Regarding current trading prices, TSMRF is priced at $23.20, while NPPNY trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas NPPNY's P/E ratio is 9.65. In terms of profitability, TSMRF's ROE is +0.09%, compared to NPPNY's ROE of +0.11%. Regarding short-term risk, TSMRF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check NPPNY's competition here
TSMRF vs SHPHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, TSMRF is priced at $23.20, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, TSMRF's ROE is +0.09%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, TSMRF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check SHPHF's competition here
TSMRF vs CMOPF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CMOPF has a market cap of 1.6B. Regarding current trading prices, TSMRF is priced at $23.20, while CMOPF trades at $103.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CMOPF's P/E ratio is -391.00. In terms of profitability, TSMRF's ROE is +0.09%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, TSMRF is more volatile compared to CMOPF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check CMOPF's competition here
TSMRF vs MITPF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, TSMRF is priced at $23.20, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas MITPF's P/E ratio is -10.81. In terms of profitability, TSMRF's ROE is +0.09%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, TSMRF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check MITPF's competition here
TSMRF vs KARBF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, TSMRF is priced at $23.20, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas KARBF's P/E ratio is 262.50. In terms of profitability, TSMRF's ROE is +0.09%, compared to KARBF's ROE of N/A. Regarding short-term risk, TSMRF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check KARBF's competition here
TSMRF vs SWGHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, TSMRF is priced at $23.20, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, TSMRF's ROE is +0.09%, compared to SWGHF's ROE of +0.06%. Regarding short-term risk, TSMRF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check SWGHF's competition here
TSMRF vs CASBF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CASBF has a market cap of 1.2B. Regarding current trading prices, TSMRF is priced at $23.20, while CASBF trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CASBF's P/E ratio is 177.50. In terms of profitability, TSMRF's ROE is +0.09%, compared to CASBF's ROE of -0.00%. Regarding short-term risk, TSMRF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check CASBF's competition here
TSMRF vs EVOTF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, EVOTF has a market cap of 1.2B. Regarding current trading prices, TSMRF is priced at $23.20, while EVOTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas EVOTF's P/E ratio is -5.27. In terms of profitability, TSMRF's ROE is +0.09%, compared to EVOTF's ROE of -0.25%. Regarding short-term risk, TSMRF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check EVOTF's competition here
TSMRF vs LJUIF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, TSMRF is priced at $23.20, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, TSMRF's ROE is +0.09%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, TSMRF is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check LJUIF's competition here
TSMRF vs BIOGY Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, TSMRF is priced at $23.20, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, TSMRF's ROE is +0.09%, compared to BIOGY's ROE of +0.26%. Regarding short-term risk, TSMRF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check BIOGY's competition here
TSMRF vs CHIZF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CHIZF has a market cap of 1.1B. Regarding current trading prices, TSMRF is priced at $23.20, while CHIZF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CHIZF's P/E ratio is -21.89. In terms of profitability, TSMRF's ROE is +0.09%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, TSMRF is less volatile compared to CHIZF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CHIZF's competition here
TSMRF vs KSPHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, TSMRF is priced at $23.20, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas KSPHF's P/E ratio is 12.39. In terms of profitability, TSMRF's ROE is +0.09%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, TSMRF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check KSPHF's competition here
TSMRF vs GNMLF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, TSMRF is priced at $23.20, while GNMLF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas GNMLF's P/E ratio is 10.80. In terms of profitability, TSMRF's ROE is +0.09%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, TSMRF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check GNMLF's competition here
TSMRF vs KKPCF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, TSMRF is priced at $23.20, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, TSMRF's ROE is +0.09%, compared to KKPCF's ROE of +0.01%. Regarding short-term risk, TSMRF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check KKPCF's competition here
TSMRF vs GLASF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, GLASF has a market cap of 886.5M. Regarding current trading prices, TSMRF is priced at $23.20, while GLASF trades at $11.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas GLASF's P/E ratio is -16.59. In terms of profitability, TSMRF's ROE is +0.09%, compared to GLASF's ROE of -0.26%. Regarding short-term risk, TSMRF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check GLASF's competition here
TSMRF vs TWAPF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, TSMRF is priced at $23.20, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, TSMRF's ROE is +0.09%, compared to TWAPF's ROE of +0.03%. Regarding short-term risk, TSMRF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check TWAPF's competition here
TSMRF vs CSWYF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, TSMRF is priced at $23.20, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, TSMRF's ROE is +0.09%, compared to CSWYF's ROE of +0.12%. Regarding short-term risk, TSMRF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check CSWYF's competition here
TSMRF vs TRXPF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, TSMRF is priced at $23.20, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, TSMRF's ROE is +0.09%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, TSMRF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check TRXPF's competition here
TSMRF vs SHEZF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SHEZF has a market cap of 689M. Regarding current trading prices, TSMRF is priced at $23.20, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, TSMRF's ROE is +0.09%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, TSMRF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check SHEZF's competition here
TSMRF vs YIHCF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, TSMRF is priced at $23.20, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, TSMRF's ROE is +0.09%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, TSMRF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check YIHCF's competition here
TSMRF vs AIHLF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, TSMRF is priced at $23.20, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, TSMRF's ROE is +0.09%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, TSMRF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check AIHLF's competition here
TSMRF vs TRSSF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, TSMRF is priced at $23.20, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, TSMRF's ROE is +0.09%, compared to TRSSF's ROE of -0.75%. Regarding short-term risk, TSMRF is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check TRSSF's competition here
TSMRF vs KHTRF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, KHTRF has a market cap of 589.2M. Regarding current trading prices, TSMRF is priced at $23.20, while KHTRF trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas KHTRF's P/E ratio is 150.25. In terms of profitability, TSMRF's ROE is +0.09%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, TSMRF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check KHTRF's competition here
TSMRF vs AGYTF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, AGYTF has a market cap of 554.6M. Regarding current trading prices, TSMRF is priced at $23.20, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, TSMRF's ROE is +0.09%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, TSMRF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check AGYTF's competition here
TSMRF vs BOIRF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, BOIRF has a market cap of 553.9M. Regarding current trading prices, TSMRF is priced at $23.20, while BOIRF trades at $31.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas BOIRF's P/E ratio is 24.17. In terms of profitability, TSMRF's ROE is +0.09%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, TSMRF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check BOIRF's competition here
TSMRF vs PKBFF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, TSMRF is priced at $23.20, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas PKBFF's P/E ratio is N/A. In terms of profitability, TSMRF's ROE is +0.09%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, TSMRF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check PKBFF's competition here
TSMRF vs CCHWF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, TSMRF is priced at $23.20, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, TSMRF's ROE is +0.09%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, TSMRF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CCHWF's competition here
TSMRF vs VRNOF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, TSMRF is priced at $23.20, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, TSMRF's ROE is +0.09%, compared to VRNOF's ROE of -0.31%. Regarding short-term risk, TSMRF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check VRNOF's competition here
TSMRF vs PEXXF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, TSMRF is priced at $23.20, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, TSMRF's ROE is +0.09%, compared to PEXXF's ROE of N/A. Regarding short-term risk, TSMRF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check PEXXF's competition here
TSMRF vs HUMDF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HUMDF has a market cap of 430.9M. Regarding current trading prices, TSMRF is priced at $23.20, while HUMDF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HUMDF's P/E ratio is 2.70. In terms of profitability, TSMRF's ROE is +0.09%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, TSMRF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check HUMDF's competition here
TSMRF vs SWDCF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SWDCF has a market cap of 399.6M. Regarding current trading prices, TSMRF is priced at $23.20, while SWDCF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SWDCF's P/E ratio is 83.33. In terms of profitability, TSMRF's ROE is +0.09%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, TSMRF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check SWDCF's competition here
TSMRF vs ELTP Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, ELTP has a market cap of 370.2M. Regarding current trading prices, TSMRF is priced at $23.20, while ELTP trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas ELTP's P/E ratio is 8.59. In terms of profitability, TSMRF's ROE is +0.09%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, TSMRF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check ELTP's competition here
TSMRF vs CRLBF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CRLBF has a market cap of 322.6M. Regarding current trading prices, TSMRF is priced at $23.20, while CRLBF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CRLBF's P/E ratio is -2.47. In terms of profitability, TSMRF's ROE is +0.09%, compared to CRLBF's ROE of -0.35%. Regarding short-term risk, TSMRF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check CRLBF's competition here
TSMRF vs CPHRF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CPHRF has a market cap of 306.3M. Regarding current trading prices, TSMRF is priced at $23.20, while CPHRF trades at $12.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CPHRF's P/E ratio is 10.18. In terms of profitability, TSMRF's ROE is +0.09%, compared to CPHRF's ROE of +0.26%. Regarding short-term risk, TSMRF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check CPHRF's competition here
TSMRF vs GUERF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, TSMRF is priced at $23.20, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas GUERF's P/E ratio is 8.19. In terms of profitability, TSMRF's ROE is +0.09%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, TSMRF is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check GUERF's competition here
TSMRF vs BHCCF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, TSMRF is priced at $23.20, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, TSMRF's ROE is +0.09%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, TSMRF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check BHCCF's competition here
TSMRF vs NIKA Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, NIKA has a market cap of 211.8M. Regarding current trading prices, TSMRF is priced at $23.20, while NIKA trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas NIKA's P/E ratio is N/A. In terms of profitability, TSMRF's ROE is +0.09%, compared to NIKA's ROE of +0.27%. Regarding short-term risk, TSMRF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check NIKA's competition here
TSMRF vs PLNHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, TSMRF is priced at $23.20, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, TSMRF's ROE is +0.09%, compared to PLNHF's ROE of +838111.55%. Regarding short-term risk, TSMRF is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check PLNHF's competition here
TSMRF vs CBWTF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CBWTF has a market cap of 149M. Regarding current trading prices, TSMRF is priced at $23.20, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CBWTF's P/E ratio is 10.62. In terms of profitability, TSMRF's ROE is +0.09%, compared to CBWTF's ROE of +0.16%. Regarding short-term risk, TSMRF is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check CBWTF's competition here
TSMRF vs COPHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, TSMRF is priced at $23.20, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas COPHF's P/E ratio is -0.02. In terms of profitability, TSMRF's ROE is +0.09%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, TSMRF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check COPHF's competition here
TSMRF vs NWPN Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, TSMRF is priced at $23.20, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas NWPN's P/E ratio is -0.04. In terms of profitability, TSMRF's ROE is +0.09%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, TSMRF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check NWPN's competition here
TSMRF vs LOVFF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, LOVFF has a market cap of 123.5M. Regarding current trading prices, TSMRF is priced at $23.20, while LOVFF trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas LOVFF's P/E ratio is 15.63. In terms of profitability, TSMRF's ROE is +0.09%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, TSMRF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check LOVFF's competition here
TSMRF vs AAWH Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, AAWH has a market cap of 117.7M. Regarding current trading prices, TSMRF is priced at $23.20, while AAWH trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas AAWH's P/E ratio is -0.91. In terms of profitability, TSMRF's ROE is +0.09%, compared to AAWH's ROE of +5.41%. Regarding short-term risk, TSMRF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check AAWH's competition here
TSMRF vs BIOYF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, BIOYF has a market cap of 116.6M. Regarding current trading prices, TSMRF is priced at $23.20, while BIOYF trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas BIOYF's P/E ratio is 17.79. In terms of profitability, TSMRF's ROE is +0.09%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, TSMRF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check BIOYF's competition here
TSMRF vs LPCUF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, TSMRF is priced at $23.20, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, TSMRF's ROE is +0.09%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, TSMRF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check LPCUF's competition here
TSMRF vs CNVCF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, TSMRF is priced at $23.20, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, TSMRF's ROE is +0.09%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, TSMRF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check CNVCF's competition here
TSMRF vs JUSHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, JUSHF has a market cap of 104.4M. Regarding current trading prices, TSMRF is priced at $23.20, while JUSHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas JUSHF's P/E ratio is -1.45. In terms of profitability, TSMRF's ROE is +0.09%, compared to JUSHF's ROE of +0.66%. Regarding short-term risk, TSMRF is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check JUSHF's competition here
TSMRF vs GRUSF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, GRUSF has a market cap of 102.8M. Regarding current trading prices, TSMRF is priced at $23.20, while GRUSF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas GRUSF's P/E ratio is 41.15. In terms of profitability, TSMRF's ROE is +0.09%, compared to GRUSF's ROE of +0.01%. Regarding short-term risk, TSMRF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check GRUSF's competition here
TSMRF vs HLTRF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, HLTRF has a market cap of 102M. Regarding current trading prices, TSMRF is priced at $23.20, while HLTRF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas HLTRF's P/E ratio is -10.19. In terms of profitability, TSMRF's ROE is +0.09%, compared to HLTRF's ROE of -0.17%. Regarding short-term risk, TSMRF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check HLTRF's competition here
TSMRF vs MEDXF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, MEDXF has a market cap of 91.2M. Regarding current trading prices, TSMRF is priced at $23.20, while MEDXF trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas MEDXF's P/E ratio is -141.25. In terms of profitability, TSMRF's ROE is +0.09%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, TSMRF is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check MEDXF's competition here
TSMRF vs CWBHF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, CWBHF has a market cap of 85.7M. Regarding current trading prices, TSMRF is priced at $23.20, while CWBHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas CWBHF's P/E ratio is -2.32. In terms of profitability, TSMRF's ROE is +0.09%, compared to CWBHF's ROE of -20.65%. Regarding short-term risk, TSMRF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CWBHF's competition here
TSMRF vs SHIEF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, SHIEF has a market cap of 85.5M. Regarding current trading prices, TSMRF is priced at $23.20, while SHIEF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas SHIEF's P/E ratio is -4.00. In terms of profitability, TSMRF's ROE is +0.09%, compared to SHIEF's ROE of +1.01%. Regarding short-term risk, TSMRF is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check SHIEF's competition here
TSMRF vs ABSCF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, ABSCF has a market cap of 78.1M. Regarding current trading prices, TSMRF is priced at $23.20, while ABSCF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas ABSCF's P/E ratio is -37.33. In terms of profitability, TSMRF's ROE is +0.09%, compared to ABSCF's ROE of +0.07%. Regarding short-term risk, TSMRF is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for TSMRF.Check ABSCF's competition here
TSMRF vs ORXOF Comparison May 2026
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.7B. In comparison, ORXOF has a market cap of 73.8M. Regarding current trading prices, TSMRF is priced at $23.20, while ORXOF trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 10.04, whereas ORXOF's P/E ratio is -1.63. In terms of profitability, TSMRF's ROE is +0.09%, compared to ORXOF's ROE of -2.28%. Regarding short-term risk, TSMRF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check ORXOF's competition here